Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
April 21 2018 - 3:37AM
Accelerate Diagnostics, Inc. today announced the sizeable
release of new data presented by the company, its customers, and
clinical experts during the European Congress of Clinical
Microbiology and Infectious Diseases (ECCMID) 2018, located
in IFEMA – Feria de Madrid, Madrid, Spain, April 21 – 24th.
The symposium presentations on Monday, April 23, 9 – 11 a.m., in
Hall L,will focus on best practices in the management of
hospitalized patients with bacteremia using integrating
diagnostics, sepsis protocols and antimicrobial stewardship. All
presentations will be followed by Q & A sessions.
The first presentation, held 9:05 – 9:25 a.m., “Challenges of
Antibiotic Stewardship in the Critically Ill,” will be presented by
Professor Jan De Waele of Ghent University, Ghent, Belgium.
The second presentation, held 9:45 – 9:55 a.m., “Individualized
Antibiotic Therapy in Critical Care Presented,” will be presented
by Professor Fabio Taccone, ULB of Hôpital Erasme, Brussels,
Belgium.
The third presentation, held from 9:55 – 10:20 a.m., “Case
Studies in Bacteremia, Sepsis and Septic Shock,” will be presented
by Dr. Claire Thomas of Hampshire Hospitals NHS Foundation
Trust, Basingstoke, United Kingdom.The fourth presentation, held
from 10:20 to 10:30 a.m., “Critical Need to Develop Susceptibility
Testing Capacity in Clinical Laboratories” will be presented by Dr.
Romney Humphries of Accelerate Diagnostics, Tucson, USA.
Learn more or register to attend these events at:
http://eccmid-congress.org
Poster Presentations
11 poster presentations featuring performance of the Accelerate
Pheno™ system will be presented throughout the conference:
E0126 — Diagnostic accuracy of Accelerate Pheno™ system
on antimicrobial susceptibility testing in comparison to broth
microdilution method. Presented by: Tianyan Song; Tor
Monsen O0276 — MDR - XDR - PDR Gram-negatives Association
between identification and antibiotics susceptibility testing with
Accelerate Pheno™ system and the antimicrobial management of
patients with severe sepsis from the Hospital Universitario de La
Princesa. Presented by: Nelly Daniela Zurita Cruz; Laura
Llorca; Sara Gómez de Frutos; Tamara Soler Maniega; María Carmen De
las Cuevas; Laura Cardeñoso.April 21, 4:54 p.m – 4:59 p.m.,
E-poster Arena 3 O0403 — Novel experience in
diagnosing bloodstream infection
pathogens.Performance of the Accelerate Pheno™
system with five new antimicrobials for Enterobacteriaceae tested
directly from positive blood cultures. Presented by:
Dulini Gamage; Niels Oppermann; Andrew Ghusson; Aaron Sikorski,
Jesse Posey; Lindsey O’Heron; Justin Towne. April 22, 12:18 – 12:28
p.m., Hall H O0749 — Rapid antimicrobial susceptibility
testing – state of the art.Assessing the clinical
impact of rapid pathogen identification (ID) and antimicrobial
susceptibility testing (AST) provided by the Accelerate Pheno™
system at Hampshire Hospitals NHS Foundation Trust (HHFT).
Presented by: Stephen Peter Kidd; Stephen Poole; Nathan Moore;
Christina Petridou, Kordo Saeed; Claire Thomas; Nick Cortes; Nicki
Hutchinson. April 23, 12:00 – 12:05 p.m., E-poster Arena 2
P1788 — Rapid antimicrobial susceptibility testing – what
can we expect?Comparative evaluation of Accelerate
Pheno™ system and Vitek® 2 systems for rapid antibiotic
susceptibility testing of pathogens in positive blood
cultures. Presented by: Giulia De Angelis; Teresa Spanu;
Tiziana D’Inzeo; Giulia Menchinelli; Patrizia Posteraro; Gabriella
Parisi; Maurizio Sanguinett; Brunella Posteraro. ECCMID Poster Hall
P1791 — Rapid antimicrobial susceptibility testing
comparison of the Accelerate Pheno™ system test results from
Gram-negative bacilli (GNB) parallel-seeded to FA-plus blood
culture bottles (BCB) incubated in bioMerieux BacT/Alert-3D and
VirtuO systems. Presented by: Barbara M. Willey; Anthony
Oppedisano; Ebuka Osuji; Yaroslav Sokolskyy; Mustafa Al-Ani; Herman
Ng; Aimee Paterson; Pauline Lo; Tony Mazzulli; Susan Poutanen.
ECCMID Poster Hall P1796 — Rapid antimicrobial
susceptibility testingAccelerating
time-to-pathogen-adapted antibiotic treatment through
subculture-independent phenotypic AST in patients suffering from
sepsis. Presented by: Matthias Karrasch; Marco Bender;
Jennifer Geraci; Jürgen Rödel; Frank Martin Brunkhorst; Bettina
Löffler. ECCMID Poster Hall P1937 — Rapid antimicrobial
susceptibility testingComparison of the Accelerate
Pheno™ system with the conventional methods for the identification
and antimicrobial susceptibility testing of positive blood
cultures. Presented by: Mirko Buttrini; Adriana Calderaro;
Monica Martinelli; Silvia Covan; Sara Montecchini; Alberto Ruggeri;
Maria Cristina Arcangeletti; Flora De Conto; Carlo Chezzi. ECCMID
Poster Hall P1944 — Diagnostic approaches in bacterial
bloodstream infectionEvaluation of the Accelerate
Pheno™ system for the diagnosis of bloodstream infections (BSIs) in
bacterial bloodstream infection. Presented by: Giuseppe
Giuliani; Marina Re; Luisa Re; Cristina Rescaldani; Lora Manolia;
Roberto Ottaviano. ECCMID Poster Hall P1949 — Diagnostic
approaches in bacterial bloodstream
infection.Evaluation of Accelerate Pheno™ system,
a rapid identification and antibiotic susceptibility testing (AST)
system, in the Hospital Universatario de la Princesa.
Presented by: Nelly Daniela Zurita Cruz; Laura Llorca; Sara Gómez
de Frutos; Belén Fernández-Caso; Tamara Soler Maniega; María Carmen
De las Cuevas; Laura Cardeñoso. ECCMID Poster Hall P1951 —
Diagnostic approaches in bacterial bloodstream
infectionAccelerate Pheno™ system test: the
experience of the microbiology and virology laboratory – San
Camillo Hospital – Rome. Presented by: Paola Maria
Placanica; Gabriella Parisi; Bruno Mariani; Rosa Maria Oliverio;
Mariarosa Gaudio; Daniela Orazi. ECCMID Poster Hall
About the Congress
Recognized as the largest European congress covering its fields,
ECCMID is the 28th European Congress of Clinical Microbiology and
Infectious Diseases, organized on April 21 and lasting till 24
April 2018 in Madrid, Spain. The congress, hosted by the European
Society for Clinical Microbiology and Infectious Diseases (ESCMID),
is expected to attract more than 12,000 clinical investigators,
scientists and medical professionals related to the fields of
microbiology and infectious diseases. The congress focuses on
sharing and delivering educational sessions on recent advancements
in research and clinical experience in the field of infectious
diseases, infection control and clinical microbiology.
For more information visit www.eccmid.org or search
#ECCMID2018.
About Accelerate Diagnostics, Inc.Accelerate
Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company
dedicated to providing solutions for the global challenge of
antibiotic resistance and healthcare-associated infections. The
company recently obtained FDA marketing authorization for
antimicrobial susceptibility testing direct from positive blood
culture samples using its Accelerate PhenoTM system and Accelerate
PhenoTestTM BC kit. The system and kit leverage proprietary
molecular identification methods and morphokinetic cellular
analysis (MCA) to provide minimum inhibitory concentrations for a
range of applicable antibiotics. The fully-automated system is
designed to eliminate the lengthy culture and sample preparation
steps required prior to antimicrobial susceptibility testing.
Recent studies suggest the solution offers results 1-2 days faster
than conventional methods, enabling clinicians to optimize
antibiotic selection, dosage, and infusion strategy specific to the
individual patient and their infection.
The "ACCELERATE DIAGNOSTICS" and "ACCELERATE PHENO" and
"ACCELERATE PHENOTEST" and diamond shaped logos and marks are
trademarks or registered trademarks of Accelerate Diagnostics,
Inc.
Media Contact:
Andrew Chasteen, Accelerate Diagnostics, achasteen@axdx.com, +1 520 404-0809
Accelerate Diagnostics (NASDAQ:AXDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Accelerate Diagnostics (NASDAQ:AXDX)
Historical Stock Chart
From Apr 2023 to Apr 2024